Please seeaccompanyingfullPrescribing Information Indications Atopic Dermatitis:DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when...
Sanofiand Regeneron are committed to helping patients in the US who are prescribed Dupixent gain access to the medicine and receive the support they may need with the DUPIXENTMyWay®program. For more information, please call 1-844-DUPIXENT (1-844-387-4936) or visitwww.DUPIXEN...
“Patients with uncontrolled COPD have been waiting for a new treatment approach for many years, so we are thrilled to bring to market the first biologic to target an underlying cause of this devastating disease to reduce COPD exacerbations and improve lung function,” saidPaul ...
corticosteroid dependent asthma; as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP), and for the treatment of adult and pediatric patients aged 12 years and older, weighing at least 40 kg, with eosinophilic esophagitis ...
Dupixent dosing for asthma for children aged 6 to 11 years: Body weightInitial Dupixent dose and subsequent dose 15 to less than 30 kg300 mg every four weeks (Q4W) 30 kg or more200 mg every other week (Q2W) See theDupixent Prescribing Informationfor Dupixent dosing for children aged 6 ...
This is not all the information you need to know about Dupixent for safe and effective use. Results among patients are variable and your results may be different. Review the full Dupixent information here, and discuss this information and questions with your doctor or other health care provider....
designed to help patients, caregivers, and information seekers throughout the DUPIXENT treatment journey. SIGN UP Choose your condition: Uncontrolled moderate-to-severe eczema Uncontrolled moderate-to-severe eosinophilic or oral steroid dependent asthma ...
corticosteroid dependent asthma; as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP), and for the treatment of adult and pediatric patients aged 12 years and older, weighing at least 40 kg, with eosinophilic esophagitis ...
Be inspired by the journeys of real patients on DUPIXENT. Since startingDupixent, I feel like my symptoms are more controlled. It was like I finally saw the cracks in my opponent and understood how to outmaneuver them. I’ve got clearer skin, less itch, and I feel like the court is min...
Earlier this year, the FDA granted Breakthrough Therapy designation for Dupixent as an add-on maintenance treatment in adult patients with uncontrolled COPD associated with a history of exacerbations and an eosinophilic phenotype based on the positive results from BOREAS. ...